These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3882369)

  • 1. A clinical algorithm to determine the etiology of brittle diabetes.
    Schade DS; Eaton RP; Drumm DA; Duckworth WC
    Diabetes Care; 1985; 8(1):5-11. PubMed ID: 3882369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The etiology of incapacitating, brittle diabetes.
    Schade DS; Drumm DA; Duckworth WC; Eaton RP
    Diabetes Care; 1985; 8(1):12-20. PubMed ID: 3971842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brittle diabetes: etiology and treatment.
    Schade DS; Burge MR
    Adv Endocrinol Metab; 1995; 6():289-319. PubMed ID: 7671100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion).
    Pickup J; Williams G; Johns P; Keen H
    Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572
    [No Abstract]   [Full Text] [Related]  

  • 7. Management strategies for brittle diabetes.
    Vantyghem MC; Press M
    Ann Endocrinol (Paris); 2006 Sep; 67(4):287-96. PubMed ID: 17072232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of brittle diabetes: 12 year follow up.
    Tattersall R; Gregory R; Selby C; Kerr D; Heller S
    BMJ; 1991 May; 302(6787):1240-3. PubMed ID: 1904287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia.
    Maker AV; Sheikh R; Bhagia V;
    Langenbecks Arch Surg; 2017 Sep; 402(6):873-883. PubMed ID: 28733926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of brittle diabetes.
    Williams G; Pickup JC
    Diabetes Res; 1988 Jan; 7(1):13-8. PubMed ID: 3042251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A treatable cause of recurrent severe hypoglycemia.
    Hardy KJ; Burge MR; Boyle PJ; Scarpello JH
    Diabetes Care; 1994 Jul; 17(7):722-4. PubMed ID: 7924785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
    Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
    Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
    Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.
    Bolli GB; Dimitriadis GD; Pehling GB; Baker BA; Haymond MW; Cryer PE; Gerich JE
    N Engl J Med; 1984 Jun; 310(26):1706-11. PubMed ID: 6374455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severely unstable diabetes (brittle diabetes)--diagnostic and therapeutic questions].
    Otto-Buczkowska E; Chobot-Jarosz P
    Przegl Lek; 1996; 53(6):491-6. PubMed ID: 8927752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
    Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
    N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cortical functioning with acute hypoglycemia and hyperglycemia in type I diabetes.
    Hoffman RG; Speelman DJ; Hinnen DA; Conley KL; Guthrie RA; Knapp RK
    Diabetes Care; 1989 Mar; 12(3):193-7. PubMed ID: 2702910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.